GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genenta Science SPA (NAS:GNTA) » Definitions » Price-to-Funds-From-Operations

Genenta Science SPA (Genenta Science SPA) Price-to-Funds-From-Operations : (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genenta Science SPA Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Genenta Science SPA (Genenta Science SPA) Business Description

Industry
Traded in Other Exchanges
Address
Via Olgettina No. 58, Milan, ITA, 20132
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's lead product includes Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain, and TEMs -Immuno-Gene Therapy.